{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:46:23Z","timestamp":1789505183822,"version":"build-2803163510"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00204-023-03529-w","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T19:01:40Z","timestamp":1685386900000},"page":"2069-2087","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The relevance of acid sphingomyelinase as a potential target for therapeutic intervention in hepatic disorders: current scenario and anticipated trends"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9250-0322","authenticated-orcid":false,"given":"Ishfaq Hassan","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2339-997X","authenticated-orcid":false,"given":"Chinnasamy","family":"Thirunavukkarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"key":"3529_CR1","doi-asserted-by":"publisher","first-page":"102596","DOI":"10.1016\/j.redox.2022.102596","volume":"59","author":"C Alarc\u00f3n-Vila","year":"2023","unstructured":"Alarc\u00f3n-Vila C, Insausti-Urkia N, Torres S, Segal\u00e9s-Rovira P, Conde de la Rosa L, Nu\u00f1ez S, Fucho R, Fern\u00e1ndez-Checa JC, Garc\u00eda-Ruiz C (2023) Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis. Redox Biol 59:102596. https:\/\/doi.org\/10.1016\/j.redox.2022.102596","journal-title":"Redox Biol"},{"issue":"1","key":"3529_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/26895293.2022.2078894","volume":"15","author":"AA Al-Bari","year":"2022","unstructured":"Al-Bari AA (2022) Inhibition of autolysosomes by repurposing drugs as a promising therapeutic strategy for the treatment of cancers. All Life 15(1):568\u2013601. https:\/\/doi.org\/10.1080\/26895293.2022.2078894","journal-title":"All Life"},{"issue":"7\u20138","key":"3529_CR3","first-page":"218","volume":"35","author":"S Albouz","year":"1981","unstructured":"Albouz S, Hauw JJ, Berwald-Netter Y, Boutry JM, Bourdon R, Baumann N (1981) Tricyclic anti-depressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures. Biomedicine 35(7\u20138):218\u2013220","journal-title":"Biomedicine"},{"key":"3529_CR4","doi-asserted-by":"publisher","unstructured":"Anthony HF (eds), Ridgway ND, McLeod RS (2021) Biochemistry of lipids, lipoproteins and membranes (seventh edition) chapter 9\u2014sphingolipids. Elsevier, , pp 281\u2013316. https:\/\/doi.org\/10.1016\/B978-0-12-824048-9.00009-2(ISBN9780128240489)","DOI":"10.1016\/B978-0-12-824048-9.00009-2"},{"key":"3529_CR6","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/srep18017","volume":"5","author":"A Baulies","year":"2015","unstructured":"Baulies A, Ribas V, N\u00fa\u00f1ez S, Torres S, Alarc\u00f3n-Vila C, Mart\u00ednez L, Suda J, Ybanez MD, Kaplowitz N, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC (2015) Lysosomal cholesterol accumulation sensitizes to acetaminophen hepatotoxicity by impairing mitophagy. Sci Rep 5:18017. https:\/\/doi.org\/10.1038\/srep18017","journal-title":"Sci Rep"},{"issue":"2","key":"3529_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1515\/BC.2007.021","volume":"388","author":"S Becker","year":"2007","unstructured":"Becker S, Reinehr R, Grether-Beck S, Eberle A, H\u00e4ussinger D (2007) Hydrophobic bile salts trigger ceramide formation through endosomal acidification. Biol Chem 388(2):185\u2013196. https:\/\/doi.org\/10.1515\/BC.2007.021","journal-title":"Biol Chem"},{"key":"3529_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fphys.2014.00331","volume":"5","author":"N Beckmann","year":"2014","unstructured":"Beckmann N, Sharma D, Gulbins E, Becker KA, Edelmann B (2014) Inhibition of acid sphingomyelinase by tricyclic anti-depressants and analogons. Front Physiol 5:331. https:\/\/doi.org\/10.3389\/fphys.2014.00331","journal-title":"Front Physiol"},{"issue":"4","key":"3529_CR125","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jhep.2007.07.001","volume":"47","author":"CJ Brewer","year":"2007","unstructured":"Brewer CJ (2007) A brand new mechanism for copper toxicity. J Hepatol 47(4):621\u2013622. https:\/\/doi.org\/10.1016\/j.jhep.2007.07.001","journal-title":"Journal of Hepatology"},{"issue":"3","key":"3529_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/0005-2736(79)90397-3","volume":"555","author":"WI Calhoun","year":"1979","unstructured":"Calhoun WI, Shipley GG (1979) Fatty acid composition and thermal behavior of natural sphingomyelins. Biochimica Et Biophysica Acta (BBA) Biomembranes 555(3):436\u2013441. https:\/\/doi.org\/10.1016\/0005-2736(79)90397-3","journal-title":"Biochimica Et Biophysica Acta (BBA) Biomembranes"},{"issue":"4","key":"3529_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1476-5381.2011.01279.x","volume":"163","author":"D Canals","year":"2011","unstructured":"Canals D, Perry DM, Jenkins RW, Hannun YA (2011) Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases. Br J Pharmacol 163(4):694\u2013712. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01279.x","journal-title":"Br J Pharmacol"},{"issue":"8","key":"3529_CR11","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.xcrm.2020.100142","volume":"1","author":"A Carpinteiro","year":"2020","unstructured":"Carpinteiro A, Edwards MJ, Hoffmann M, Kochs G, Gripp B, Weigang S, Adams C, Carpinteiro E, Gulbins A, Keitsch S, Sehl C, Soddemann M, Wilker B, Kamler M, Bertsch T, Lang KS, Patel S, Wilson GC, Walter S, Hengel H, Gulbins E (2020) Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells. Cell Rep Med 1(8):100142. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100142","journal-title":"Cell Rep Med"},{"issue":"18","key":"3529_CR12","doi-asserted-by":"publisher","first-page":"24995","DOI":"10.18632\/oncotarget.8735","volume":"7","author":"D Cervia","year":"2016","unstructured":"Cervia D, Assi E, De Palma C, Giovarelli M, Bizzozero L, Pambianco S, Di Renzo I, Zecchini S, Moscheni C, Vantaggiato C, Procacci P, Clementi E, Perrotta C (2016) Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin. Oncotarget 7(18):24995\u201325009. https:\/\/doi.org\/10.18632\/oncotarget.8735","journal-title":"Oncotarget"},{"key":"3529_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-6331-9_1","volume":"991","author":"M Chakraborty","year":"2013","unstructured":"Chakraborty M, Jiang XC (2013) Sphingomyelin and its role in cellular signaling. Adv Exp Med Biol 991:1\u201314. https:\/\/doi.org\/10.1007\/978-94-007-6331-9_1","journal-title":"Adv Exp Med Biol"},{"issue":"22","key":"3529_CR14","doi-asserted-by":"publisher","first-page":"20917","DOI":"10.1074\/jbc.R400040200","volume":"280","author":"TY Chang","year":"2005","unstructured":"Chang TY, Reid PC, Sugii S, Ohgami N, Cruz JC, Chang CC (2005) Niemann-Pick type C disease and intracellular cholesterol trafficking. J Biol Chem 280(22):20917\u201320920. https:\/\/doi.org\/10.1074\/jbc.R400040200","journal-title":"J Biol Chem"},{"issue":"19","key":"3529_CR15","doi-asserted-by":"publisher","first-page":"19196","DOI":"10.1074\/jbc.M412867200","volume":"280","author":"A Charruyer","year":"2005","unstructured":"Charruyer A, Grazide S, Bezombes C, M\u00fcller S, Laurent G, Jaffr\u00e9zou JP (2005) UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently on a nuclear signal. J Biol Chem 280(19):19196\u201319204. https:\/\/doi.org\/10.1074\/jbc.M412867200","journal-title":"J Biol Chem"},{"key":"3529_CR16","doi-asserted-by":"publisher","first-page":"592737","DOI":"10.3389\/fphar.2020.592737","volume":"11","author":"CZ Chen","year":"2021","unstructured":"Chen CZ, Shinn P, Itkin Z, Eastman RT, Bostwick R, Rasmussen L, Huang R, Shen M, Hu X, Wilson KM, Brooks BM, Guo H, Zhao T, Klump-Thomas C, Simeonov A, Michael SG, Lo DC, Hall MD, Zheng W (2021) Drug repurposing screen for compounds inhibiting the cytopathic effect of SARS-CoV-2. Front Pharmacol 11:592737. https:\/\/doi.org\/10.3389\/fphar.2020.592737","journal-title":"Front Pharmacol"},{"issue":"6","key":"3529_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/acsptsci.0c00112","volume":"3","author":"CZ Chen","year":"2020","unstructured":"Chen CZ, Xu M, Pradhan M, Gorshkov K, Petersen JD, Straus MR, Zhu W, Shinn P, Guo H, Shen M, Klumpp-Thomas C, Michael SG, Zimmerberg J, Zheng W, Whittaker GR (2020) Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles. ACS Pharmacol Transl Sci 3(6):1165\u20131175. https:\/\/doi.org\/10.1021\/acsptsci.0c00112","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"3529_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1128\/MCB.00719-15","volume":"36","author":"KJ Cho","year":"2015","unstructured":"Cho KJ, van der Hoeven D, Zhou Y, Maekawa M, Ma X, Chen W, Fairn GD, Hancock JF (2015) Inhibition of acid sphingomyelinase depletes cellular phosphatidylserine and mislocalizes K-Ras from the plasma membrane. Mol Cell Biol 36(2):363\u2013374. https:\/\/doi.org\/10.1128\/MCB.00719-15","journal-title":"Mol Cell Biol"},{"key":"3529_CR19","doi-asserted-by":"publisher","first-page":"616500","DOI":"10.3389\/fmed.2020.616500","volume":"7","author":"HY Chung","year":"2021","unstructured":"Chung HY, Claus RA (2021) Keep your friends close, but your enemies closer: role of acid sphingomyelinase during infection and host response. Front Med 7:616500. https:\/\/doi.org\/10.3389\/fmed.2020.616500","journal-title":"Front Med"},{"issue":"10","key":"3529_CR20","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3390\/ijms19103163","volume":"19","author":"HY Chung","year":"2018","unstructured":"Chung HY, Witt CJ, Hurtado-Oliveros J, Wickel J, Gr\u00e4ler MH, Lupp A, Claus RA (2018) Acid sphingomyelinase inhibition stabilizes hepatic ceramide content and improves hepatic biotransformation capacity in a murine model of polymicrobial sepsis. Int J Mol Sci 19(10):3163. https:\/\/doi.org\/10.3390\/ijms19103163","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3529_CR21","doi-asserted-by":"publisher","first-page":"12348","DOI":"10.1038\/s41598-017-11837-2","volume":"7","author":"HY Chung","year":"2017","unstructured":"Chung HY, Witt CJ, Jbeily N, Hurtado-Oliveros J, Giszas B, Lupp A, Gr\u00e4ler MH, Bruns T, Stallmach A, Gonnert FA, Claus RA (2017) Acid sphingomyelinase inhibition prevents development of sepsis sequelae in the murine liver. Sci Rep 7(1):12348. https:\/\/doi.org\/10.1038\/s41598-017-11837-2","journal-title":"Sci Rep"},{"issue":"9","key":"3529_CR22","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1194\/jlr.M700069-JLR200","volume":"48","author":"O Coll","year":"2007","unstructured":"Coll O, Morales A, Fern\u00e1ndez-Checa JC, Garcia-Ruiz C (2007) Neutral sphingomyelinase-induced ceramide triggers germinal vesicle breakdown and oxidant-dependent apoptosis in Xenopus laevis oocytes. J Lipid Res 48(9):1924\u20131935. https:\/\/doi.org\/10.1194\/jlr.M700069-JLR200","journal-title":"J Lipid Res"},{"issue":"8","key":"3529_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.4161\/auto.25063","volume":"9","author":"MJ Czaja","year":"2013","unstructured":"Czaja MJ, Ding WX, Donohue TM Jr, Friedman SL, Kim JS, Komatsu M, Lemasters JJ, Lemoine A, Lin JD, Ou JH, Perlmutter DH, Randall G, Ray RB, Tsung A, Yin XM (2013) Functions of autophagy in normal and diseased liver. Autophagy 9(8):1131\u20131158. https:\/\/doi.org\/10.4161\/auto.25063","journal-title":"Autophagy"},{"key":"3529_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2350-8-79","volume":"8","author":"Z Dastani","year":"2007","unstructured":"Dastani Z, Ruel IL, Engert JC, Genest J Jr, Marcil M (2007) Sphingomyelin phosphodiesterase-1 (SMPD1) coding variants do not contribute to low levels of high-density lipoprotein cholesterol. BMC Med Genet 8:79. https:\/\/doi.org\/10.1186\/1471-2350-8-79","journal-title":"BMC Med Genet"},{"key":"3529_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fimmu.2015.00203","volume":"6","author":"J De Toro","year":"2015","unstructured":"De Toro J, Herschlik L, Waldner C, Mongini C (2015) Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol 6:203. https:\/\/doi.org\/10.3389\/fimmu.2015.00203","journal-title":"Front Immunol"},{"issue":"Suppl","key":"3529_CR27","doi-asserted-by":"publisher","first-page":"S412","DOI":"10.1194\/jlr.R800089-JLR200","volume":"50","author":"SK Erickson","year":"2009","unstructured":"Erickson SK (2009) Non-alcoholic fatty liver disease. J Lipid Res 50(Suppl):S412\u2013S416. https:\/\/doi.org\/10.1194\/jlr.R800089-JLR200","journal-title":"J Lipid Res"},{"issue":"4","key":"3529_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jhep.2013.05.023","volume":"59","author":"A Fernandez","year":"2013","unstructured":"Fernandez A, Matias N, Fucho R, Ribas V, Von Montfort C, Nu\u00f1o N, Baulies A, Martinez L, Tarrats N, Mari M, Colell A, Morales A, Dubuquoy L, Mathurin P, Bataller R, Caballeria J, Elena M, Balsinde J, Kaplowitz N, Garcia-Ruiz C, Fernandez-Checa JC (2013) ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. J Hepatol 59(4):805\u2013813. https:\/\/doi.org\/10.1016\/j.jhep.2013.05.023","journal-title":"J Hepatol"},{"issue":"5","key":"3529_CR29","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2014.06.009","volume":"61","author":"R Fucho","year":"2014","unstructured":"Fucho R, Mart\u00ednez L, Baulies A, Torres S, Tarrats N, Fernandez A, Ribas V, Astudillo AM, Balsinde J, Garcia-Rov\u00e9s P, Elena M, Bergheim I, Lotersztajn S, Trautwein C, Appelqvist H, Paton AW, Paton JC, Czaja MJ, Kaplowitz N, Fernandez-Checa JC, Garc\u00eda-Ruiz C (2014) ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis. J Hepatol 61(5):1126\u20131134. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.009","journal-title":"J Hepatol"},{"issue":"6","key":"3529_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/cdd.2014.4","volume":"21","author":"E Gaband\u00e9-Rodr\u00edguez","year":"2014","unstructured":"Gaband\u00e9-Rodr\u00edguez E, Boya P, Labrador V, Dotti CG, Ledesma MD (2014) High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A. Cell Death Differ 21(6):864\u2013875. https:\/\/doi.org\/10.1038\/cdd.2014.4","journal-title":"Cell Death Differ"},{"issue":"1","key":"3529_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jhep.2014.09.023","volume":"62","author":"C Garcia-Ruiz","year":"2015","unstructured":"Garcia-Ruiz C, Mato JM, Vance D, Kaplowitz N, Fern\u00e1ndez-Checa JC (2015) Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways. J Hepatol 62(1):219\u2013233. https:\/\/doi.org\/10.1016\/j.jhep.2014.09.023","journal-title":"J Hepatol"},{"issue":"7","key":"3529_CR32","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.ymthe.2017.05.014","volume":"25","author":"C Garnacho","year":"2017","unstructured":"Garnacho C, Dhami R, Solomon M, Schuchman EH, Muro S (2017) Enhanced delivery and effects of acid sphingomyelinase by ICAM-1-targeted nanocarriers in type B Niemann-Pick disease mice. Mol Ther 25(7):1686\u20131696. https:\/\/doi.org\/10.1016\/j.ymthe.2017.05.014","journal-title":"Mol Ther"},{"key":"3529_CR33","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.1038\/ncomms12196","volume":"7","author":"A Gorelik","year":"2016","unstructured":"Gorelik A, Illes K, Heinz LX, Superti-Furga G, Nagar B (2016) Crystal structure of mammalian acid sphingomyelinase. Nat Commun 7:12196. https:\/\/doi.org\/10.1038\/ncomms12196","journal-title":"Nat Commun"},{"issue":"7","key":"3529_CR34","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.bbalip.2014.04.007","volume":"1841","author":"G Grammatikos","year":"2014","unstructured":"Grammatikos G, M\u00fchle C, Ferreiros N, Schroeter S, Bogdanou D, Schwalm S, Hintereder G, Kornhuber J, Zeuzem S, Sarrazin C, Pfeilschifter J (2014) Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease. Biochem Biophys Acta 1841(7):1012\u20131020. https:\/\/doi.org\/10.1016\/j.bbalip.2014.04.007","journal-title":"Biochem Biophys Acta"},{"key":"3529_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm823","volume":"9","author":"H Grassm\u00e9","year":"2003","unstructured":"Grassm\u00e9 H, Jendrossek V, Riehle A et al (2003) Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9:322\u2013330. https:\/\/doi.org\/10.1038\/nm823","journal-title":"Nat Med"},{"issue":"7","key":"3529_CR36","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1074\/jbc.M310979200","volume":"279","author":"S Gupta","year":"2004","unstructured":"Gupta S, Natarajan R, Payne SG, Studer EJ, Spiegel S, Dent P, Hylemon PB (2004) Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes. Role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation. J Biol Chem 279(7):5821\u20135828","journal-title":"J Biol Chem"},{"issue":"4","key":"3529_CR37","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/jcm10040792","volume":"10","author":"E Hajduch","year":"2021","unstructured":"Hajduch E, Lachkar F, Ferr\u00e9 P, Foufelle F (2021) Roles of ceramides in non-alcoholic fatty liver disease. J Clin Med 10(4):792. https:\/\/doi.org\/10.3390\/jcm10040792","journal-title":"J Clin Med"},{"key":"3529_CR38","doi-asserted-by":"publisher","unstructured":"Han D, Kaplowitz N (eds) (2015) Mitochondria in liver disease, 1st edn. CRC Press, Boca Raton. https:\/\/doi.org\/10.1201\/b19420","DOI":"10.1201\/b19420"},{"issue":"20","key":"3529_CR39","doi-asserted-by":"publisher","first-page":"13565","DOI":"10.1074\/jbc.M708916200","volume":"283","author":"N Hanawa","year":"2008","unstructured":"Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N (2008) Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 283(20):13565\u201313577. https:\/\/doi.org\/10.1074\/jbc.M708916200","journal-title":"J Biol Chem"},{"issue":"29","key":"3529_CR124","doi-asserted-by":"publisher","first-page":"25847","DOI":"10.1074\/jbc.R200008200","volume":"277","author":"YA Hannun","year":"2002","unstructured":"Hannun YA, Obied LM (2002) The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277(29):25847\u201325850. https:\/\/doi.org\/10.1074\/jbc.R200008200","journal-title":"Journal of Biological Chemistry"},{"key":"3529_CR40","doi-asserted-by":"publisher","first-page":"15926","DOI":"10.1038\/srep15926","volume":"5","author":"S Hebbar","year":"2015","unstructured":"Hebbar S, Sahoo I, Matysik A et al (2015) Ceramides and stress signalling intersect with autophagic defects in neurodegenerative Drosophila blue cheese (bchs) mutants. Sci Rep 5:15926. https:\/\/doi.org\/10.1038\/srep15926","journal-title":"Sci Rep"},{"key":"3529_CR41","doi-asserted-by":"publisher","first-page":"100089","DOI":"10.1016\/j.jlr.2021.100089","volume":"62","author":"V Hinkovska-Galcheva","year":"2021","unstructured":"Hinkovska-Galcheva V, Treadwell T, Shillingford JM, Lee A, Abe A, Tesmer JJG, Shayman JA (2021) Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis. J Lipid Res 62:100089. https:\/\/doi.org\/10.1016\/j.jlr.2021.100089","journal-title":"J Lipid Res"},{"key":"3529_CR42","doi-asserted-by":"publisher","unstructured":"Hoertel N, S\u00e1nchez-Rico M, Gulbins E, Kornhuber J, Carpinteiro A, Lenze EJ, Reiersen AM, Abell\u00e1n M, de la Muela P, Vernet R, Blanco C, Cougoule C, Beeker N, Neuraz A, Gorwood P, Alvarado JM, Meneton P, Limosin F, AP-HP\/Universit\u00e9 de Paris\/INSERM COVID-19 research collaboration, AP-HP COVID CDR Initiative, \"Entrep\u00f4t de Donn\u00e9es de Sant\u00e9\" AP-HP Consortium (2021) Association between FIASMAs and reduced risk of intubation or death in individuals hospitalized for severe COVID-19: an observational multicenter study. Clin Pharmacol Ther 110(6):1498\u20131511. https:\/\/doi.org\/10.1002\/cpt.2317","DOI":"10.1002\/cpt.2317"},{"key":"3529_CR44","doi-asserted-by":"publisher","first-page":"109420","DOI":"10.1016\/j.cbi.2021.109420","volume":"338","author":"Y Hou","year":"2021","unstructured":"Hou Y, Ge S, Li X, Wang C, He H, He L (2021) Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis. Chemico-Biol Interact 338:109420. https:\/\/doi.org\/10.1016\/j.cbi.2021.109420","journal-title":"Chemico-Biol Interact"},{"issue":"1","key":"3529_CR45","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ajpath.2016.09.005","volume":"187","author":"E Hubel","year":"2017","unstructured":"Hubel E, Saroha A, Park WJ, Pewzner-Jung Y, Lavoie EG, Futerman AH, Bruck R, Fishman S, Dranoff JA, Shibolet O, Zvibel I (2017) Sortilin deficiency reduces ductular reaction, hepatocyte apoptosis, and liver fibrosis in cholestatic-induced liver injury. Am J Pathol 187(1):122\u2013133. https:\/\/doi.org\/10.1016\/j.ajpath.2016.09.005","journal-title":"Am J Pathol"},{"issue":"7","key":"3529_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1515\/bchm3.1994.375.7.447","volume":"375","author":"R Hurwitz","year":"1994","unstructured":"Hurwitz R, Ferlinz K, Sandhoff K (1994) The tricyclic anti-depressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Bio Chem Hoppe-Seyler 375(7):447\u2013450. https:\/\/doi.org\/10.1515\/bchm3.1994.375.7.447","journal-title":"Bio Chem Hoppe-Seyler"},{"issue":"5","key":"3529_CR47","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/2211-5463.13153","volume":"11","author":"K Imamura","year":"2021","unstructured":"Imamura K, Sakurai Y, Enami T, Shibukawa R, Nishi Y, Ohta A, Shu T, Kawaguchi J, Okada S, Hoenen T, Yasuda J, Inoue H (2021) iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility. FEBS Open Bio 11(5):1452\u20131464. https:\/\/doi.org\/10.1002\/2211-5463.13153","journal-title":"FEBS Open Bio"},{"issue":"11","key":"3529_CR48","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/biom10111497","volume":"10","author":"N Insausti-Urkia","year":"2020","unstructured":"Insausti-Urkia N, Solsona-Vilarrasa E, Garcia-Ruiz C, Fernandez-Checa JC (2020) Sphingomyelinases and liver diseases. Biomolecules 10(11):1497. https:\/\/doi.org\/10.3390\/biom10111497","journal-title":"Biomolecules"},{"issue":"5","key":"3529_CR50","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1074\/jbc.M110.155234","volume":"286","author":"RW Jenkins","year":"2011","unstructured":"Jenkins RW, Idkowiak-Baldys J, Simbari F, Canals D, Roddy P, Riner CD, Clarke CJ, Hannun YA (2011) A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing. J Biol Chem 286(5):3777\u20133788. https:\/\/doi.org\/10.1074\/jbc.M110.155234","journal-title":"J Biol Chem"},{"issue":"7","key":"3529_CR51","doi-asserted-by":"publisher","first-page":"e00819","DOI":"10.1128\/AAC.00819-20","volume":"64","author":"S Jeon","year":"2020","unstructured":"Jeon S, Ko M, Lee J, Choi I, Byun SY, Park S, Shum D, Kim S (2020) Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob Agents Chemother 64(7):e00819-e820. https:\/\/doi.org\/10.1128\/AAC.00819-20","journal-title":"Antimicrob Agents Chemother"},{"key":"3529_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-physiol-012110-142233","volume":"73","author":"L Jia","year":"2011","unstructured":"Jia L, Betters JL, Yu L (2011) Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol 73:239\u2013259. https:\/\/doi.org\/10.1146\/annurev-physiol-012110-142233","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"3529_CR53","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1194\/jlr.M080242","volume":"59","author":"MJ Justice","year":"2018","unstructured":"Justice MJ, Bronova I, Schweitzer KS, Poirier C, Blum JS, Berdyshev EV, Petrache I (2018) Inhibition of acid sphingomyelinase disrupts LYNUS signaling and triggers autophagy. J Lipid Res 59(4):596\u2013606. https:\/\/doi.org\/10.1194\/jlr.M080242","journal-title":"J Lipid Res"},{"issue":"12","key":"3529_CR56","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1111\/j.1742-4658.2007.05848.x","volume":"274","author":"Y Kato","year":"2007","unstructured":"Kato Y, Ozawa S, Tsukuda M, Kubota E, Miyazaki K, St-Pierre Y, Hata R (2007) Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma. FEBS J 274(12):3171\u20133183. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.05848.x","journal-title":"FEBS J"},{"issue":"4","key":"3529_CR57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/cells11040667","volume":"11","author":"AR Kho","year":"2022","unstructured":"Kho AR, Choi BY, Lee SH, Hong DK, Kang BS, Lee SH, Suh SW (2022) Administration of an acidic sphingomyelinase (ASMase) inhibitor, imipramine, reduces hypoglycemia-induced hippocampal neuronal death. Cells 11(4):667. https:\/\/doi.org\/10.3390\/cells11040667","journal-title":"Cells"},{"issue":"7","key":"3529_CR58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-2005-870235","volume":"37","author":"P Knapp","year":"2005","unstructured":"Knapp P, Dobrzy\u0144 A, G\u00f3rski J (2005) Ceramides, sphinganine, sphingosine and acid sphingomyelinases in the human umbilical cord blood. Hormone Metab 37(7):433\u2013437. https:\/\/doi.org\/10.1055\/s-2005-870235","journal-title":"Hormone Metab"},{"issue":"1\u20133","key":"3529_CR59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0014-5793(04)00033-X","volume":"559","author":"M K\u00f6lzer","year":"2004","unstructured":"K\u00f6lzer M, Werth N, Sandhoff K (2004) Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic anti-depressant desipramine. FEBS Lett 559(1\u20133):96\u201398. https:\/\/doi.org\/10.1016\/S0014-5793(04)00033-X","journal-title":"FEBS Lett"},{"issue":"9","key":"3529_CR60","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3390\/ph14090894","volume":"14","author":"J Kornhuber","year":"2021","unstructured":"Kornhuber J, Gulbins E (2021) New molecular targets for anti-depressant drugs. Pharmaceuticals (Basel, Switzerland) 14(9):894. https:\/\/doi.org\/10.3390\/ph14090894","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"8","key":"3529_CR61","doi-asserted-by":"publisher","first-page":"e23852","DOI":"10.1371\/journal.pone.0023852","volume":"6","author":"J Kornhuber","year":"2011","unstructured":"Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, M\u00fchle C, Terfloth L, Groemer TW, Spitzer GM, Liedl KR, Gulbins E, Tripal P (2011) Identification of novel functional inhibitors of acid sphingomyelinase. PLoS ONE 6(8):e23852. https:\/\/doi.org\/10.1371\/journal.pone.0023852","journal-title":"PLoS ONE"},{"issue":"1","key":"3529_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000315101","volume":"26","author":"J Kornhuber","year":"2010","unstructured":"Kornhuber J, Tripal P, Reichel M, M\u00fchle C, Rhein C, Muehlbacher M, Groemer TW, Gulbins E (2010) Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 26(1):9\u201320. https:\/\/doi.org\/10.1159\/000315101","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"3529_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/jm070524a","volume":"51","author":"J Kornhuber","year":"2008","unstructured":"Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, Gulbins E (2008) Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. J Med Chem 51(2):219\u2013237. https:\/\/doi.org\/10.1021\/jm070524a","journal-title":"J Med Chem"},{"issue":"2","key":"3529_CR64","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nm1539","volume":"13","author":"PA Lang","year":"2007","unstructured":"Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, R\u00fcbben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, H\u00e4ussinger D, Gulbins E, Lang F (2007) Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 13(2):164\u2013170. https:\/\/doi.org\/10.1038\/nm1539","journal-title":"Nat Med"},{"issue":"1","key":"3529_CR65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/hep.20293","volume":"40","author":"WM Lee","year":"2004","unstructured":"Lee WM (2004) Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology (baltimore, MD) 40(1):6\u20139. https:\/\/doi.org\/10.1002\/hep.20293","journal-title":"Hepatology (baltimore, MD)"},{"issue":"8","key":"3529_CR66","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20132451","volume":"211","author":"JK Lee","year":"2014","unstructured":"Lee JK, Jin HK, Park MH, Kim BR, Lee PH, Nakauchi H, Carter JE, He X, Schuchman EH, Bae JS (2014) Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer\u2019s disease. J Exp Med 211(8):1551\u20131570. https:\/\/doi.org\/10.1084\/jem.20132451","journal-title":"J Exp Med"},{"key":"3529_CR67","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fcell.2019.00378","volume":"7","author":"C Li","year":"2020","unstructured":"Li C, Guo S, Pang W, Zhao Z (2020) Crosstalk between acid sphingomyelinase and inflammasome signaling and their emerging roles in tissue injury and fibrosis. Front Cell Dev Biol 7:378. https:\/\/doi.org\/10.3389\/fcell.2019.00378","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3529_CR68","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00109-014-1120-y","volume":"92","author":"X Li","year":"2014","unstructured":"Li X, Xu M, Pitzer AL, Xia M, Boini KM, Li PL, Zhang Y (2014) Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis. J Mol Med (Berl) 92(5):473\u2013485. https:\/\/doi.org\/10.1007\/s00109-014-1120-y","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"3529_CR69","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/hep.21285","volume":"44","author":"L Llacuna","year":"2006","unstructured":"Llacuna L, Mar\u00ed M, Garcia-Ruiz C, Fernandez-Checa JC, Morales A (2006) Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology (baltimore, MD) 44(3):561\u2013572. https:\/\/doi.org\/10.1002\/hep.21285","journal-title":"Hepatology (baltimore, MD)"},{"issue":"6","key":"3529_CR71","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1172\/JCI19852","volume":"113","author":"M Mar\u00ed","year":"2004","unstructured":"Mar\u00ed M, Colell A, Morales A, Pa\u00f1eda C, Varela-Nieto I, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC (2004) Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J Clin Investig 113(6):895\u2013904. https:\/\/doi.org\/10.1172\/JCI19852","journal-title":"J Clin Investig"},{"issue":"3","key":"3529_CR74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1087057104272546","volume":"10","author":"RJ Mintzer","year":"2005","unstructured":"Mintzer RJ, Appell KC, Cole A, Johns A, Pagila R, Polokoff MA, Tabas I, Snider RM, Meurer-Ogden JA (2005) A novel high-throughput screening format to identify inhibitors of secreted acid sphingomyelinase. J Biomol Screen 10(3):225\u2013234. https:\/\/doi.org\/10.1177\/1087057104272546","journal-title":"J Biomol Screen"},{"issue":"11","key":"3529_CR75","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/cbin.11670","volume":"45","author":"IH Mir","year":"2021","unstructured":"Mir IH, Guha S, Behera J, Thirunavukkarasu C (2021) Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy. Cell Biol Int 45(11):2161\u20132177. https:\/\/doi.org\/10.1002\/cbin.11670","journal-title":"Cell Biol Int"},{"key":"3529_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30190","author":"IH Mir","year":"2021","unstructured":"Mir IH, Jyothi KC, Thirunavukkarasu C (2022) The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: current scenario and future anticipation. J Cell Biochem 123(10):1607-1623. https:\/\/doi.org\/10.1002\/jcb.30190.\u00a0","journal-title":"J Cell Biochem"},{"key":"3529_CR77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","volume":"5","author":"S Mitra","year":"2020","unstructured":"Mitra S, De A, Chowdhury A (2020) Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol 5:16. https:\/\/doi.org\/10.21037\/tgh.2019.09.08","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"3","key":"3529_CR78","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2353\/ajpath.2010.091257","volume":"177","author":"A Moles","year":"2010","unstructured":"Moles A, Tarrats N, Morales A, Dom\u00ednguez M, Bataller R, Caballer\u00eda J, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC, Mar\u00ed M (2010) Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis. Am J Pathol 177(3):1214\u20131224. https:\/\/doi.org\/10.2353\/ajpath.2010.091257","journal-title":"Am J Pathol"},{"issue":"5","key":"3529_CR79","doi-asserted-by":"publisher","first-page":"E1030","DOI":"10.1152\/ajpendo.00343.2009","volume":"297","author":"M Nomura","year":"2009","unstructured":"Nomura M, Ishii H, Kawakami A, Yoshida M (2009) Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance. Am J Physiol Endocrinol Metab 297(5):E1030\u2013E1038. https:\/\/doi.org\/10.1152\/ajpendo.00343.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5102","key":"3529_CR80","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1126\/science.8456305","volume":"259","author":"LM Obeid","year":"1993","unstructured":"Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science (New York, NY) 259(5102):1769\u20131771. https:\/\/doi.org\/10.1126\/science.8456305","journal-title":"Science (New York, NY)"},{"key":"3529_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.chemphyslip.2018.11.003","volume":"218","author":"S Parashuraman","year":"2019","unstructured":"Parashuraman S, D\u2019Angelo G (2019) Visualizing sphingolipid biosynthesis in cells. Chem Phys Lipid 218:103\u2013111. https:\/\/doi.org\/10.1016\/j.chemphyslip.2018.11.003","journal-title":"Chem Phys Lipid"},{"issue":"5","key":"3529_CR82","doi-asserted-by":"publisher","first-page":"e4767","DOI":"10.7759\/cureus.4767","volume":"11","author":"B Pati\u00f1o-Escobar","year":"2019","unstructured":"Pati\u00f1o-Escobar B, Solano MH, Zarabanda L, Casas CP, Castro C (2019) Niemann-Pick disease: an approach for diagnosis in adulthood. Cureus 11(5):e4767. https:\/\/doi.org\/10.7759\/cureus.4767","journal-title":"Cureus"},{"issue":"5","key":"3529_CR83","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10495-015-1101-9","volume":"20","author":"C Perrotta","year":"2015","unstructured":"Perrotta C, Cervia D, De Palma C, Assi E, Pellegrino P, Bassi MT, Clementi E (2015) The emerging role of acid sphingomyelinase in autophagy. Apoptosis 20(5):635\u2013644. https:\/\/doi.org\/10.1007\/s10495-015-1101-9","journal-title":"Apoptosis"},{"issue":"3","key":"3529_CR84","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","volume":"24","author":"NH Petersen","year":"2013","unstructured":"Petersen NH, Olsen OD, Groth-Pedersen L, Ellegaard AM, Bilgin M, Redmer S, Ostenfeld MS, Ulanet D, Dovmark TH, L\u00f8nborg A, Vindel\u00f8v SD, Hanahan D, Arenz C, Ejsing CS, Kirkegaard T, Rohde M, Nylandsted J, J\u00e4\u00e4ttel\u00e4 M (2013) Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell 24(3):379\u2013393. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.003","journal-title":"Cancer Cell"},{"issue":"11","key":"3529_CR85","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.3390\/cells10113201","volume":"10","author":"S Peters","year":"2021","unstructured":"Peters S, Fohmann I, Rudel T, Schubert-Unkmeir A (2021) A comprehensive review on the interplay between Neisseria spp. and host sphingolipid metabolites. Cells 10(11):3201. https:\/\/doi.org\/10.3390\/cells10113201","journal-title":"Cells"},{"issue":"3","key":"3529_CR86","doi-asserted-by":"publisher","first-page":"106274","DOI":"10.1016\/j.ijantimicag.2020.106274","volume":"57","author":"M Plaze","year":"2021","unstructured":"Plaze M, Attali D, Prot M, Petit AC, Blatzer M, Vinckier F, Levillayer L, Chiaravalli J, Perin-Dureau F, Cachia A, Friedlander G, Chr\u00e9tien F, Simon-Loriere E, Gaillard R (2021) Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine. Int J Antimicrob Agents 57(3):106274. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106274","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"3529_CR87","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3529_CR88","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/hepr.12352","volume":"45","author":"RC Quillin 3rd","year":"2015","unstructured":"Quillin RC 3rd, Wilson GC, Nojima H, Freeman CM, Wang J, Schuster RM, Blanchard JA, Edwards MJ, Gandhi CR, Gulbins E, Lentsch AB (2015) Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice. Hepatol Res 45(3):305\u2013314. https:\/\/doi.org\/10.1111\/hepr.12352","journal-title":"Hepatol Res"},{"issue":"48","key":"3529_CR89","doi-asserted-by":"publisher","first-page":"38104","DOI":"10.1074\/jbc.M005296200","volume":"275","author":"JW Reagan Jr","year":"2000","unstructured":"Reagan JW Jr, Hubbert ML, Shelness GS (2000) Posttranslational regulation of acid sphingomyelinase in niemann-pick type C1 fibroblasts and free cholesterol-enriched chinese hamster ovary cells. J Biol Chem 275(48):38104\u201338110. https:\/\/doi.org\/10.1074\/jbc.M005296200","journal-title":"J Biol Chem"},{"key":"3529_CR90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biochi.2018.07.021","volume":"159","author":"M R\u00e9gnier","year":"2019","unstructured":"R\u00e9gnier M, Polizzi A, Guillou H, Loiseau N (2019) Sphingolipid metabolism in non-alcoholic fatty liver diseases. Biochimie 159:9\u201322. https:\/\/doi.org\/10.1016\/j.biochi.2018.07.021","journal-title":"Biochimie"},{"key":"3529_CR91","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbrc.2020.11.095","volume":"538","author":"LR Reznikov","year":"2021","unstructured":"Reznikov LR, Norris MH, Vashisht R, Bluhm AP, Li D, Liao YJ, Brown A, Butte AJ, Ostrov DA (2021) Identification of antiviral antihistamines for COVID-19 repurposing. Biochem Biophys Res Commun 538:173\u2013179. https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.095","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"3529_CR93","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/a:1007041329052","volume":"205","author":"E Romiti","year":"2000","unstructured":"Romiti E, Vasta V, Meacci E, Farnararo M, Linke T, Ferlinz K, Sandhoff K, Bruni P (2000) characterization of sphingomyelinase activity released by thrombin-stimulated platelets. Mol Cell Biochem 205(1\u20132):75\u201381. https:\/\/doi.org\/10.1023\/a:1007041329052","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"3529_CR95","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jcmgh.2016.10.003","volume":"3","author":"T Sanada","year":"2016","unstructured":"Sanada T, Hirata Y, Naito Y, Yamamoto N, Kikkawa Y, Ishida Y, Yamasaki C, Tateno C, Ochiya T, Kohara M (2016) Transmission of HBV DNA mediated by ceramide-triggered extracellular vesicles. Cell Mol Gastroenterol Hepatol 3(2):272\u2013283. https:\/\/doi.org\/10.1016\/j.jcmgh.2016.10.003","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"3529_CR96","doi-asserted-by":"publisher","first-page":"e65620","DOI":"10.1371\/journal.pone.0065620","volume":"8","author":"R Savi\u0107","year":"2013","unstructured":"Savi\u0107 R, He X, Fiel I, Schuchman EH (2013) Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancer. PLoS ONE 8(5):e65620. https:\/\/doi.org\/10.1371\/journal.pone.0065620","journal-title":"PLoS ONE"},{"issue":"2","key":"3529_CR97","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000323886","volume":"29","author":"F Scaglioni","year":"2011","unstructured":"Scaglioni F, Ciccia S, Marino M, Bedogni G, Bellentani S (2011) ASH and NASH. Dig Dis (Basel, Switzerland) 29(2):202\u2013210. https:\/\/doi.org\/10.1159\/000323886","journal-title":"Dig Dis (Basel, Switzerland)"},{"issue":"1","key":"3529_CR98","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1080\/22221751.2020.1829082","volume":"9","author":"S Schloer","year":"2020","unstructured":"Schloer S, Brunotte L, Goretzko J, Mecate-Zambrano A, Korthals N, Gerke V, Ludwig S, Rescher U (2020) Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the anti-depressant fluoxetine. Emerg Microbes Infect 9(1):2245\u20132255. https:\/\/doi.org\/10.1080\/22221751.2020.1829082","journal-title":"Emerg Microbes Infect"},{"issue":"1\u20132","key":"3529_CR99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","volume":"120","author":"EH Schuchman","year":"2017","unstructured":"Schuchman EH, Desnick RJ (2017) Types A and B Niemann-Pick disease. Mol Genet Metab 120(1\u20132):27\u201333. https:\/\/doi.org\/10.1016\/j.ymgme.2016.12.008","journal-title":"Mol Genet Metab"},{"issue":"3","key":"3529_CR100","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/tera.1420070306","volume":"7","author":"JU Schweichel","year":"1973","unstructured":"Schweichel JU, Merker HJ (1973) The morphology of various types of cell death in prenatal tissues. Teratology 7(3):253\u2013266. https:\/\/doi.org\/10.1002\/tera.1420070306","journal-title":"Teratology"},{"issue":"6633","key":"3529_CR101","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/42408","volume":"387","author":"K Simons","year":"1997","unstructured":"Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387(6633):569\u2013572. https:\/\/doi.org\/10.1038\/42408","journal-title":"Nature"},{"issue":"9","key":"3529_CR102","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/mt.2008.145","volume":"16","author":"EL Smith","year":"2008","unstructured":"Smith EL, Schuchman EH (2008) Acid sphingomyelinase overexpression enhances the antineoplastic effects of irradiation in vitro and in vivo. Mol Ther 16(9):1565\u20131571. https:\/\/doi.org\/10.1038\/mt.2008.145","journal-title":"Mol Ther"},{"issue":"7","key":"3529_CR103","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.18632\/oncotarget.6982","volume":"7","author":"M Stefanovic","year":"2016","unstructured":"Stefanovic M, Tutusaus A, Martinez-Nieto GA, B\u00e1rcena C, de Gregorio E, Moutinho C, Barbero-Camps E, Villanueva A, Colell A, Mar\u00ed M, Garc\u00eda-Ruiz C, Fernandez-Checa JC, Morales A (2016) Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma. Oncotarget 7(7):8253\u20138267. https:\/\/doi.org\/10.18632\/oncotarget.6982","journal-title":"Oncotarget"},{"issue":"12","key":"3529_CR104","doi-asserted-by":"publisher","first-page":"20067","DOI":"10.18632\/oncotarget.15379","volume":"8","author":"M Stephan","year":"2017","unstructured":"Stephan M, Edelmann B, Winoto-Morbach S, Janssen O, Bertsch U, Perrotta C, Sch\u00fctze S, Fritsch J (2017) Role of caspases in CD95-induced biphasic activation of acid sphingomyelinase. Oncotarget 8(12):20067\u201320085. https:\/\/doi.org\/10.18632\/oncotarget.15379","journal-title":"Oncotarget"},{"issue":"47","key":"3529_CR105","doi-asserted-by":"publisher","first-page":"39898","DOI":"10.1074\/jbc.M112.416552","volume":"287","author":"M Taniguchi","year":"2012","unstructured":"Taniguchi M, Kitatani K, Kondo T, Hashimoto-Nishimura M, Asano S, Hayashi A, Mitsutake S, Igarashi Y, Umehara H, Takeya H, Kigawa J, Okazaki T (2012) Regulation of autophagy and its associated cell death by \u201csphingolipid rheostat\u201d: reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway. J Biol Chem 287(47):39898\u201339910. https:\/\/doi.org\/10.1074\/jbc.M112.416552","journal-title":"J Biol Chem"},{"issue":"4","key":"3529_CR106","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nm1748","volume":"14","author":"V Teichgr\u00e4ber","year":"2008","unstructured":"Teichgr\u00e4ber V, Ulrich M, Endlich N, Riethm\u00fcller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von K\u00fcrthy G, Schmid KW, Weller M, T\u00fcmmler B, Lang F, Grassme H, D\u00f6ring G, Gulbins E (2008) Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14(4):382\u2013391. https:\/\/doi.org\/10.1038\/nm1748","journal-title":"Nat Med"},{"issue":"1","key":"3529_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1091\/mbc.E14-05-1028","volume":"26","author":"KA Toops","year":"2015","unstructured":"Toops KA, Tan LX, Jiang Z, Radu RA, Lakkaraju A (2015) Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium. Mol Biol Cell 26(1):1\u201314. https:\/\/doi.org\/10.1091\/mbc.E14-05-1028","journal-title":"Mol Biol Cell"},{"key":"3529_CR108","doi-asserted-by":"publisher","first-page":"111997","DOI":"10.1016\/j.jphotobiol.2020.111997","volume":"211","author":"AM Udrea","year":"2020","unstructured":"Udrea AM, Avram S, Nistorescu S, Pascu ML, Romanitan MO (2020) Laser irradiated phenothiazines: new potential treatment for COVID-19 explored by molecular docking. J Photochem Photobiol B Biol 211:111997. https:\/\/doi.org\/10.1016\/j.jphotobiol.2020.111997","journal-title":"J Photochem Photobiol B Biol"},{"issue":"4","key":"3529_CR109","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/13510002.2016.1162431","volume":"22","author":"B Unal","year":"2017","unstructured":"Unal B, Ozcan F, Tuzcu H, K\u0131rac E, Elpek GO, Aslan M (2017) Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia-reperfusion injury. Redox Rep Commun Free Radic Res 22(4):147\u2013159. https:\/\/doi.org\/10.1080\/13510002.2016.1162431","journal-title":"Redox Rep Commun Free Radic Res"},{"issue":"10","key":"3529_CR111","doi-asserted-by":"publisher","first-page":"e2012201118","DOI":"10.1073\/pnas.2012201118","volume":"118","author":"EC Vatansever","year":"2021","unstructured":"Vatansever EC, Yang KS, Drelich AK, Kratch KC, Cho CC, Kempaiah KR, Hsu JC, Mellott DM, Xu S, Tseng CK, Liu WR (2021) Bepridil is potent against SARS-CoV-2 in vitro. Proc Natl Acad Sci USA 118(10):e2012201118. https:\/\/doi.org\/10.1073\/pnas.2012201118","journal-title":"Proc Natl Acad Sci USA"},{"key":"3529_CR112","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/AABC.S304649","volume":"14","author":"BO Villoutreix","year":"2021","unstructured":"Villoutreix BO, Krishnamoorthy R, Tamouza R, Leboyer M, Beaune P (2021) Chemoinformatic analysis of psychotropic and antihistaminic drugs in the light of experimental anti-SARS-CoV-2 activities. Adv Appl Bioinform Chem 14:71\u201385. https:\/\/doi.org\/10.2147\/AABC.S304649","journal-title":"Adv Appl Bioinform Chem"},{"key":"3529_CR113","doi-asserted-by":"publisher","first-page":"104929","DOI":"10.1016\/j.micpath.2021.104929","volume":"156","author":"X Wang","year":"2021","unstructured":"Wang X, Lu J, Ge S, Hou Y, Hu T, Lv Y, Wang C, He H (2021) Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro. Microb Pathog 156:104929. https:\/\/doi.org\/10.1016\/j.micpath.2021.104929","journal-title":"Microb Pathog"},{"issue":"21","key":"3529_CR115","doi-asserted-by":"publisher","first-page":"e01218","DOI":"10.1128\/JVI.01218-20","volume":"94","author":"S Weston","year":"2020","unstructured":"Weston S, Coleman CM, Haupt R, Logue J, Matthews K, Li Y, Reyes HM, Weiss SR, Frieman MB (2020) Broad Anti-coronavirus Activity of Food and Drug Administration-approved drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo. J Virol 94(21):e01218-e1220. https:\/\/doi.org\/10.1128\/JVI.01218-20","journal-title":"J Virol"},{"issue":"3","key":"3529_CR116","doi-asserted-by":"publisher","first-page":"565","DOI":"10.33594\/000000040","volume":"52","author":"BT Xia","year":"2019","unstructured":"Xia BT, Beckmann N, Winer LK, Pugh AM, Pritts TA, Nomellini V, Gulbins E, Caldwell CC (2019) Amitriptyline reduces inflammation and mortality in a murine model of sepsis. Cell Physiol Biochem 52(3):565\u2013579. https:\/\/doi.org\/10.33594\/000000040","journal-title":"Cell Physiol Biochem"},{"key":"3529_CR117","doi-asserted-by":"publisher","first-page":"586572","DOI":"10.3389\/fimmu.2020.586572","volume":"11","author":"X Xiao","year":"2020","unstructured":"Xiao X, Wang C, Chang D, Wang Y, Dong X, Jiao T, Zhao Z, Ren L, Dela Cruz CS, Sharma L, Lei X, Wang J (2020) Identification of potent and safe antiviral therapeutic candidates against SARS-CoV-2. Front Immunol 11:586572. https:\/\/doi.org\/10.3389\/fimmu.2020.586572","journal-title":"Front Immunol"},{"key":"3529_CR118","doi-asserted-by":"publisher","first-page":"609592","DOI":"10.3389\/fphar.2020.609592","volume":"11","author":"HL Xiong","year":"2021","unstructured":"Xiong HL, Cao JL, Shen CG, Ma J, Qiao XY, Shi TS, Ge SX, Ye HM, Zhang J, Yuan Q, Zhang TY, Xia NS (2021) Several FDA-approved drugs effectively inhibit SARS-CoV-2 infection in vitro. Front Pharmacol 11:609592. https:\/\/doi.org\/10.3389\/fphar.2020.609592","journal-title":"Front Pharmacol"},{"issue":"5","key":"3529_CR119","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/hep.30697","volume":"70","author":"Z Xu","year":"2019","unstructured":"Xu Z, Xu M, Liu P, Zhang S, Shang R, Qiao Y, Che L, Ribback S, Cigliano A, Evert K, Pascale RM, Dombrowski F, Evert M, Chen X, Calvisi DF, Chen X (2019) The mTORC2-Akt1 cascade is crucial for c-Myc to promote hepatocarcinogenesis in mice and humans. Hepatology (baltimore, MD) 70(5):1600\u20131613. https:\/\/doi.org\/10.1002\/hep.30697","journal-title":"Hepatology (baltimore, MD)"},{"issue":"3","key":"3529_CR120","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/alcalc\/agv119","volume":"51","author":"L Yang","year":"2016","unstructured":"Yang L, Jin GH, Zhou JY (2016) The role of ceramide in the pathogenesis of alcoholic liver disease. Alcohol Alcohol (oxford, Oxfordshire) 51(3):251\u2013257. https:\/\/doi.org\/10.1093\/alcalc\/agv119","journal-title":"Alcohol Alcohol (oxford, Oxfordshire)"},{"issue":"3","key":"3529_CR54","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1021\/acs.jmedchem.9b00739","volume":"63","author":"K Yang","year":"2020","unstructured":"Yang K, Jinying Yu, Nong K, Wang Y, Niu Ao, Chen W, Dong J, Wang J (2020) J Med Chem 63(3):961\u2013974. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00739","journal-title":"J Med Chem"},{"issue":"2","key":"3529_CR122","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1385\/JMN:15:2:85","volume":"15","author":"ZF Yu","year":"2000","unstructured":"Yu ZF, Nikolova-Karakashian M, Zhou D, Cheng G, Schuchman EH, Mattson MP (2000) Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci 15(2):85\u201397. https:\/\/doi.org\/10.1385\/JMN:15:2:85","journal-title":"J Mol Neurosci"},{"issue":"5","key":"3529_CR123","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/156652410791608225","volume":"10","author":"YH Zeidan","year":"2010","unstructured":"Zeidan YH, Hannun YA (2010) The acid sphingomyelinase\/ceramide pathway: biomedical significance and mechanisms of regulation. Curr Mol Med 10(5):454\u2013466. https:\/\/doi.org\/10.2174\/156652410791608225","journal-title":"Curr Mol Med"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03529-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-023-03529-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03529-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:34:01Z","timestamp":1744216441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-023-03529-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":112,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3529"],"URL":"https:\/\/doi.org\/10.1007\/s00204-023-03529-w","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate."}}]}}